Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
JAZZ · against 454 other Healthcare companies listed in US-listed
Ranked #138 of 455 · scores higher than 69% of peers
Bars: peers in each 10-point band of the growth score66 peers with a growth score of 80–89, including JAZZ · Click a bar to see the companies
Mainly thanks to its earnings per share growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | JAZZ | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 12.6% | 11.0% | 54% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | 6.9% | 11.0% | 39% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 460M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 441M USD | 99 | 81 | |
| 2 | 9.5B USD | 99 | 31 | |
| 2 | 87M USD | 99 | 27 | |
| 131 | 24.9B USD | 82 | 84 | |
| 131 | 5.2B USD | 82 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 64 |
| 131 | 2.6B USD | 82 | 44 |
| 138 | 623M USD | 81 | 73 |
| 138 | 15.2B USD | 81 | 65 |
| 138 | 458M USD | 81 | 29 |
| 138 | 132M USD | 81 | 31 |
| 138 | 1.6B USD | 81 | 64 |
| 138 | 2.9B USD | 81 | 56 |